X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
atopic dermatitis (49) 49
index medicus (39) 39
humans (37) 37
dermatology (34) 34
adult (24) 24
male (23) 23
female (21) 21
immunology (20) 20
allergy (19) 19
eczema (19) 19
dermatitis (17) 17
middle aged (15) 15
severity of illness index (13) 13
asthma (12) 12
dermatitis, atopic - drug therapy (12) 12
biomarkers (11) 11
dupilumab (11) 11
dermatitis, atopic - blood (10) 10
dermatitis, atopic - diagnosis (10) 10
journal article (10) 10
activation-regulated chemokine (9) 9
patients (9) 9
treatment outcome (9) 9
biomarkers - blood (8) 8
management (8) 8
placebo (8) 8
skin (8) 8
care and treatment (7) 7
cyclosporine (7) 7
dermatitis, atopic - immunology (7) 7
safety (7) 7
severity (7) 7
studies (7) 7
adult patients (6) 6
adults (6) 6
aged (6) 6
allergies (6) 6
children (6) 6
clinical trials (6) 6
cyclosporine - therapeutic use (6) 6
efficacy (6) 6
immunology and allergy (6) 6
retrospective studies (6) 6
serum thymus (6) 6
young adult (6) 6
abridged index medicus (5) 5
adolescent (5) 5
chemokine ccl17 - blood (5) 5
conjunctivitis (5) 5
corticosteroids (5) 5
cytokines (5) 5
daily practice cohort (5) 5
disease severity (5) 5
drug survival (5) 5
immunoglobulin e (5) 5
inflammatory-bowel-disease (5) 5
medical research (5) 5
medicine & public health (5) 5
psoriasis (5) 5
quality of life (5) 5
risk factors (5) 5
topical corticosteroids (5) 5
2-phase 3 trials (4) 4
allergens (4) 4
allergic diseases (4) 4
allergy and immunology (4) 4
analysis (4) 4
animals (4) 4
calcineurin inhibitors (4) 4
chemokines (4) 4
child (4) 4
corticoids (4) 4
cyclosporine-a (4) 4
dermatitis, atopic - pathology (4) 4
disease (4) 4
double-blind method (4) 4
drug therapy (4) 4
eosinophil cationic protein (4) 4
guidelines (4) 4
immunoglobulin e - blood (4) 4
immunosuppressive agents - administration & dosage (4) 4
immunosuppressive agents - adverse effects (4) 4
inflammation (4) 4
lymphocytes (4) 4
lymphocytes t (4) 4
macrophage-derived chemokine (4) 4
oral immunosuppressive drugs (4) 4
pathogenesis (4) 4
prevalence (4) 4
research (4) 4
adrenal cortex hormones - adverse effects (3) 3
allergens - immunology (3) 3
asthma - immunology (3) 3
biologics (3) 3
calcineurin (3) 3
child, preschool (3) 3
coated mycophenolate sodium (3) 3
cyclosporin a (3) 3
cyclosporine - adverse effects (3) 3
dermatitis, atopic - epidemiology (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, ISSN 1175-0561, 06/2019, Volume 20, Issue 3, pp. 443 - 456
BackgroundPatients with moderate-to-severe atopic dermatitis (AD) have increased infection risk, including skin infections and systemic infections.... 
SYSTEMIC INFECTIONS | BIOLOGIC THERAPIES | ECZEMA HERPETICUM | ADULTS | PERSISTENT ASTHMA | RISK | BACTERIAL | CORTICOSTEROIDS | SKIN BARRIER | SERIOUS INFECTIONS | DERMATOLOGY
Journal Article
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, ISSN 1610-0379, 05/2019, Volume 17, Issue 5, pp. 488 - 492
Zusammenfassung Der monoklonale Antikörper Dupilumab (Dupixent®) ist seit September 2017 in der EU als neue systemische Therapie bei mittelschwerem bis... 
Lymphocytes T
Journal Article
The Journal of Allergy and Clinical Immunology: In Practice, ISSN 2213-2198, 02/2019, Volume 7, Issue 2, pp. 753 - 754
Journal Article
The Journal of Allergy and Clinical Immunology: In Practice, ISSN 2213-2198, 02/2019, Volume 7, Issue 2, pp. 753 - 754
Journal Article
Journal of Allergy and Clinical Immunology: In Practice, ISSN 2213-2198, 02/2019, Volume 7, Issue 2, pp. 753 - 754
Journal Article
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, ISSN 1610-0379, 05/2019, Volume 17, Issue 5, pp. 488 - 491
Summary Since September 2017, the monoclonal antibody dupilumab (Dupixent®) has been approved in the EU for the treatment of moderate‐to‐severe atopic... 
2-PHASE 3 TRIALS | ADULTS | PLACEBO | ALLERGIC CONJUNCTIVITIS | EUROPEAN GUIDELINES | DERMATOLOGY | Atopic dermatitis | Conjunctivitis | Corticoids | Calcineurin | Calcineurin inhibitors | Monoclonal antibodies | Skin | Lymphocytes T | Dermatitis | Burning
Journal Article
The Journal of dermatology, ISSN 0385-2407, 08/2019, Volume 46, Issue 8, pp. 680 - 685
Systemic treatment options for chronic hand eczema are limited. Dupilumab is used in atopic dermatitis (AD) but is not licensed for (isolated) hand eczema. In... 
hand eczema | treatment | atopic dermatitis | biological | dupilumab | TOPICAL CORTICOSTEROIDS | VALIDATION | SEVERITY | LIFE | DERMATOLOGY | Atopic dermatitis | Care and treatment | Eczema | Hand | Dermatitis | Patients | Quality of life | Original
Journal Article
Pediatric dermatology, ISSN 0736-8046, 2018, Volume 35, Issue 3, pp. 378 - 383
Objectives: To study topical corticosteroid use in Dutch asthmatic children using pharmacy dispensing data and to assess whether Dutch physicians prescribe... 
treatment | topical corticosteroids | children | atopic dermatitis | asthma | longitudinal | incidence | ATOPIC-DERMATITIS | PEDIATRICS | COHORT | AGE | DERMATOLOGY | Pediatric pharmacology | Corticosteroids | Atopic dermatitis | Asthma in children | Analysis | Pharmacy | Drugstores | Infants | Corticoids | Statistical analysis | Mathematical models | Children | Prescriptions | Dermatitis | Asthma
Journal Article
The journal of allergy and clinical immunology. In practice, 02/2019, Volume 7, Issue 2, p. 753
Journal Article
Nederlands tijdschrift voor geneeskunde, ISSN 0028-2162, 03/2019, Volume 163
Dupilumab, the first registered biological for the treatment of atopic dermatitis, frequently causes adverse ocular events. These often take the form of mild... 
Journal Article
Dermatology and Therapy, ISSN 2193-8210, 12/2019, Volume 9, Issue 4, pp. 799 - 805
The Patient-Oriented Eczema Measure (POEM) assesses patient-reported frequency of atopic dermatitis (AD) symptoms, while the Children’s Dermatology Life... 
Validation | Plastic Surgery | POEM | Dermatology | Quality of Life Research | Internal Medicine | Oral and Maxillofacial Surgery | Quality of life | Responder threshold | CDLQI | Medicine & Public Health | Atopic dermatitis | Adolescents | Dupilumab
Journal Article
The Journal of Allergy and Clinical Immunology, ISSN 0091-6749, 09/2017, Volume 140, Issue 3, pp. 730 - 737
Atopic dermatitis (AD) is a complex, chronic, inflammatory skin disease with a diverse clinical presentation. However, it is unclear whether this diversity... 
endotypes | phenotypes | Atopic dermatitis | disease heterogeneity | clusters | principal component analysis | unsupervised cluster analysis | personalized medicine | Disease heterogeneity | Endotypes | Phenotypes | Immunology | Clusters | Unsupervised cluster analysis | Personalized medicine | Immunology and Allergy | Journal Article | Principal component analysis | PLACEBO | PHENOTYPE | ADULTS | PRECISION MEDICINE | IMMUNOLOGY | FEATURES | ALLERGY | DISEASE | DUPILUMAB | ASTHMA | SEVERITY | Comorbidity | Dermatitis, Atopic - epidemiology | Humans | Male | Dermatitis, Atopic - classification | Biomarkers - blood | Immunoglobulin E - blood | Immunoglobulin E - immunology | Allergens - immunology | Asthma - blood | Adult | Female | Dermatitis, Atopic - blood | Rhinitis - blood | Rhinitis - epidemiology | Asthma - epidemiology | Cytokines - blood | Analysis | Skin | Cluster analysis | Intervention | Tissue inhibitor of metalloproteinases | Immunoassay | Allergens | Clinical trials | Immunoglobulin E | CD14 antigen | Biodiversity | Dermatitis | Thymus | Variables | Interleukin 4 | Precision medicine | Eczema | Interleukin 1 | Skin diseases | Vascular endothelial growth factor | Age | Biological products | Neurodegenerative diseases | Cytokines | Principal components analysis | Data processing | Interleukin 13 | Patients | Variance analysis | Allergies | Asthma | Hypotheses | Thymic stromal lymphopoietin | Inhibitors | Biological warfare | Biomarkers | Interferon | Adults
Journal Article
Journal of the American Academy of Dermatology, 07/2019
Significant unmet need exists for long-term treatment of moderate to severe atopic dermatitis (AD). To assess the long-term safety and efficacy of dupilumab in... 
Journal Article
Clinical & Experimental Allergy, ISSN 0954-7894, 12/2019, Volume 49, Issue 12, pp. 1641 - 1644
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.